Theravance Biopharma, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Theravance Biopharma, Inc. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Payment of Exercise | F | 25.90 | 29,105 | 753,820 | 354,750 | 383.9 K to 354.8 K (-7.58 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 25.90 | 96,850 | 2,508,415 | 1,315,605 | 1.4 M to 1.3 M (-6.86 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 25.90 | 29,402 | 761,512 | 264,932 | 294.3 K to 264.9 K (-9.99 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | SABESAN VIJAY | SVP, Technical Oper ... | Payment of Exercise | F | 25.90 | 7,213 | 186,817 | 203,040 | 210.3 K to 203 K (-3.43 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 25.90 | 29,136 | 754,622 | 349,698 | 378.8 K to 349.7 K (-7.69 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Payment of Exercise | F | 25.90 | 24,392 | 631,753 | 412,920 | 437.3 K to 412.9 K (-5.58 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Payment of Exercise | F | 25.90 | 7,060 | 182,854 | 106,490 | 113.6 K to 106.5 K (-6.22 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 25.90 | 33,608 | 870,447 | 316,668 | 350.3 K to 316.7 K (-9.59 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | BRADY ANN | President, TBIL | Payment of Exercise | F | 25.90 | 5,948 | 154,053 | 105,163 | 111.1 K to 105.2 K (-5.35 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Grant | A | 0.00 | 54,000 | 0 | 383,855 | 329.9 K to 383.9 K (+16.37 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Grant | A | 0.00 | 65,000 | 0 | 329,855 | 264.9 K to 329.9 K (+24.54 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 168,000 | 0 | 1,412,455 | 1.2 M to 1.4 M (+13.50 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 170,000 | 0 | 1,244,455 | 1.1 M to 1.2 M (+15.82 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 54,000 | 0 | 294,334 | 240.3 K to 294.3 K (+22.47 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 65,000 | 0 | 240,334 | 175.3 K to 240.3 K (+37.07 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | SABESAN VIJAY | SVP, Technical Oper ... | Grant | A | 0.00 | 65,000 | 0 | 210,253 | 145.3 K to 210.3 K (+44.75 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 54,000 | 0 | 378,834 | 324.8 K to 378.8 K (+16.62 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 65,000 | 0 | 324,834 | 259.8 K to 324.8 K (+25.02 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Grant | A | 0.00 | 54,000 | 0 | 437,312 | 383.3 K to 437.3 K (+14.09 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Grant | A | 0.00 | 65,000 | 0 | 383,312 | 318.3 K to 383.3 K (+20.42 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 20,000 | 0 | 113,550 | 93.6 K to 113.6 K (+21.38 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 43,550 | 0 | 93,550 | 50 K to 93.6 K (+87.10 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 54,000 | 0 | 350,276 | 296.3 K to 350.3 K (+18.23 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 65,000 | 0 | 296,276 | 231.3 K to 296.3 K (+28.10 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | BRADY ANN | President, TBIL | Grant | A | 0.00 | 40,000 | 0 | 111,111 | 71.1 K to 111.1 K (+56.25 %) |